NeuroPace, Inc.
NPCE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13 | $18 | $7 | $19 |
| Short-Term Investments | $39 | $48 | $71 | $96 |
| Receivables | $13 | $12 | $7 | $7 |
| Inventory | $13 | $11 | $10 | $8 |
| Other Curr. Assets | $2 | $3 | $3 | $2 |
| Total Curr. Assets | $81 | $93 | $98 | $133 |
| Property Plant & Equip (Net) | $13 | $14 | $16 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $0 | $0 |
| Total NC Assets | $13 | $15 | $16 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $95 | $108 | $114 | $134 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $2 | $1 |
| Short-Term Debt | $2 | $2 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $1 | $0 | $0 |
| Other Curr. Liab. | $10 | $11 | $7 | $8 |
| Total Curr. Liab. | $15 | $16 | $11 | $9 |
| LT Debt | $71 | $71 | $68 | $50 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $71 | $71 | $68 | $51 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $14 | $15 | $17 | $0 |
| Total Liabilities | $87 | $87 | $79 | $60 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$531 | -$504 | -$471 | -$424 |
| AOCI | $0 | $0 | -$1 | -$0 |
| Other Equity | $539 | $524 | $507 | $498 |
| Total Equity | $8 | $21 | $35 | $74 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $95 | $108 | $114 | $134 |
| Net Debt | $60 | $54 | $63 | $31 |